Durante mucho tiempo no había principios uniformes para la Atribución de nombres a los antibióticos https://antibioticos-wiki.es . Más a menudo se les llama por el nombre genérico o especie del producto, con menos frecuencia-de acuerdo con la estructura química. Algunos antibióticos se nombran de acuerdo con el lugar donde se asignó el producto.
Trattamenti psicofarmacologici e disfunzioni sessuali
Sexual dysfunction related to psychotropic drugs. References (updated to 11/04/2011) Disfunzioni sessuali da psicofarmaci. Bibliografia (aggiornata al 11/04/2011)
Author:Antonio La Torre, M.D., psychiatrist. Correspondence: U.O. di Psichiatria, Ospedale di Rovereto, Rovereto (Tn), Italy. E-mail:
1. Aizenberg D, Modai I, Landa A, Gil-Ad I, Weizman A:
Comparison of sexual dysfunction in male schizophrenic patients maintained on treatment with classical antipsychotics versus clozapina. J Clin Psychiatry, 62, 7, 541-544, 2001
2. Aizenberg D, Sigler M, Zemishlany Z, Weizman A:
Lithium and male sexual function in affective patients. Clin. Neuropharmacol., 19, 515–519, 1996
3. Aizenberg D, Zemishlany Z, Dorfman-Etrog P, Weizman A:
Sexual dysfunction in male schizophrenic patients. J Clin Psychiatry, 56, (4), 137-41, 1995
Schizophrenia and sexuality: a review and a report of twelve unusual cases, part I. J Clin Psych, 41, 134–142, 1980
Schizophrenia and sexuality: a review and a report of twelve unusual cases, part II. J Clin Psych, 41, 166–174, 1980
Pharmacological treatment of rapid ejaculation. Psychiatr Clin North Am, 18, 1, 85-94, 1995
7. Althof SE, Levine SB, Corty EW, Risen CB, Stern EB, Kurit DM:
A double-bind crossover trial of clomipramine for rapid ejaculation in 15 couples. J Clin Psychiatry, 56, 9, 402-407, 1995
8. Althof SE, Resnick K, Levine S, Seftel AD, Stern E, Rosenblatt E, Risen C:
Early experience with clomipramine for rapid ejaculation. J Urol, 153, 4, 474A, 1995
Practise guidelines for the treatment of patients with schizophrenia. Second edition. April 2004
Impiego del citalopram nell'eiaculazione precoceGiorn. Italiano di Andrologia, 4, 1, 36-39, 1997
Sexual problems in healthy and depressed persons. Int. Clin. Psychopharmacol., 13, (suppl. 6), S1–S4, 1998
Improvements in SSRI/SNRI-induced sexual dysfunction by switching to escitalopramJ Sex Marital Ther, 31, 257-262, 2005
14. Assalian P, Fraser R, Tempier R, Cohen D:
Sexuality and quality of life of patients with schizophrenia. Int J Psychiatr Clin Pract., 4, 29-33, 2000
A new atypicol antipsychotic: quetiapine-induced sexual dysfunctions. Int J Imp Res., 17, 201-203, 2005
16. Atmaca M, Kuolglu M, Tezcan E, Semercioz A:
The efficacy of citalopram in the treatment of premature ejaculation: a placebo-controlled study. Int J Impot Res, 14, (6), 502-505, 2002
Sexual dysfunction in schizophrenia : focus on recent evidence. Hum Psychopharmacol., 23, 201-209, 2008
Depression and sexual dysfunction. Br Med Bull., 57, 81-99, 2001
Sexual dysfunction associated with antidepressant drugsExpert Opin Drug Saf., 3 (5), 457-70, 2004
Sexual side-effects of antidepressant and antipsychotic drug. Advances in Psychiatric Treatment, 9, 202-210, 2003
SSRI-Associated Sexual Dysfunction Am J Psychiatry , 163, 1504-1509, 2006
Issues for DSM-V: sexual dysfunction, disorder, or variation along normal distribution: toward rethinking DSM criteria of sexual dysfunctions. Am J Psychiatry, 164, 2, 198-200, 2007
Survey of treatment practices for sexual dysfunction(s) associated with anti-depressants. J Sex Marital Ther, 34, (4), 353-65, 2008
24. Balon R, Yeragani VK, Pohl R, Rasmesh C:
Sexual dysfunction during antidepressant treatment. J Clin Psychiatry, 54, 209-212, 1993
25. Bandelow B, Chouinard G, Bobes J, Ahokas A, Eggens I, Liu S, :
Extended erelease quetiapine fumarate (quetiapine XR): a once-daily monotherapy effective in generalized anxiety disorder. Data from a randomized, double-blind, placebo- and active-controlled study. Int J Neuropsychopharm (CINP), 13, 3, 305–320, 2009
26. Basson R, Berman J, Burnett A, Derogatis L, Ferguson D, Fourcroy J, Goldstein I,
Report of The International Consensus Development Conference On Female Sexual Dysfunction: Definitions and Classifications.
27. Behnke K, Sogaard J, Martin S, Bäuml J, Ravindran AV, Ågren H, Vester-Blokland ED:
Mirtazepine orally disintegrating tablet versus sertraline: a prospective onset of action study. J Clin Psychopharmacol., 23, 4, 358-364, 2003
28. Ben Zion IZ, Tessler R, Cohen L, Lerer E, Raz Y, Bachner-Melman R, Gritsenko I,
Nemanov L, Zohar AH, Belmaker RH, Benjamin J, Ebstein RP:
Polymorphisms in the dopamine D4 receptor gene (DRD4) contribute to individual differences in human sexual behavior: desire, arousal and sexual function. Molecular Psychiatry, 11, 782–786, 2006
Involuntary sperm emission with fluoxetine. Can J Psychiatry, 40, 7, 431, 1995
Management of sexual dysfunction due to antipsychotics drug therapy. Cochrane Database Syst Rev, 24, (1), CD003546, 2007
31. Biri H, Isen K, Sinik Z, Onaran M, Kupeli B, Bozkirli I:
Sertraline in the treatment of premature ejaculation : a double-blind placebo controlled study. Int Urol Nephrol, 30, 5, 611-615, 1998
32. Bishop JR, Ellingrod VL, Akroush M, Moline J:
The association of serotonin transporter genotypes and selective serotonin reuptake inhibitor (SSRI)-associated sexual side effects: possible relationship to oral contraceptives. Hum. Psychopharmacol Clin Exp., 24: 207–215, 2009
33. Bishop JR, Moline J, Ellingrod VL, Schultz SK, Clayton AH:
Serotonin 2A-1438 G/A and G-Protein Beta 3 subunit C825T polymorphisms in patients with depression and SSRI-associated sexual side effects. Neuropsychopharmacology, 31, 2281-2288, 2006
Antipsychotic treatment and sexual functioning in first-time neuroleptic-treated schizophrenic patients. Int Clin Psychopharmacol., 20, 19-21, 2005
35. Bobes J, Garcia-Portilla MP, Rejas J Hernandez G, Garcia-Garcia M, Rico-Villademoros F,
Frequency of sexual dysfunction and other reproductive side-effects in patients with schizophrenia treated with risperidone, olanzapine, quetiapine, or haloperidol: the results of the EIRE Study. J Sex Marital Ther., 29, (2), 125-147, 2003
36. Bonierbale, M., Lançon, C. & Tignol, J.:
The ELIXIR study: evaluation of sexual dysfunction in 4557 depressed patients in France. Curr. Med. Res. Opin. 19, 114–124, 2003
37. Breier A.F., Malhotra AK, Su T-P, Pinals DA, Elman I, Adler CM, Lafargue RT, Clifton A,
Clozapine and risperidone in chronic schizophrenia: effects on symptoms, parkinsonian side effects, and neuroendocrine response. Am J Psychiatry, 156, 294-298, 1999
38. Brugnoli R, Novick D, Belger M, Brown J, Germani S, Donda P, Rossi A, Pancheri P:
Effectiveness of antipsychotic treatment for schizophrenia: Italian results of the pan-European Schizophrenia Outpatient Health Outcomes (SOHO) study after 12 months. Giorn Ital Psicopat., 12, 283-292, 2006
39. Boyarsky BK, Haque W, Rouleau MR, Hirschfeld RM:
Sexual functioning in depressed outpatients taking mirtazapine. Depress Anxiety, 9, (4), 175-9, 1999
The management of medication-induced sexual dysfunctionEssential Psychopharmacology, 3, (2), 39-58, 2000
41. Byerly MJ, Lescouflair E, Weber MT, Bugno RM, Fisher R, Carmody T, Varghese F, Rush
An open-label trial of quetiapine for antipsychotic-induced sexual dysfunction.
42. Byerly MJ, Nakonezny PA, Bettcher BM, Carmody T, Fisher R, Rush AJ:
Sexual dysfunction associated with secon-generation antipsychotics in outpatients with schizophrenia or schizoaffective disorder: an empirical evaluation of olanzapine, risperidone, and quetiapine. Schizophr Res., 86, (1-3), 244-250, 2006
43. Calandra C, Terranova F, Loiacono P, Caudullo V, Russo RG, Luca M, Cafiso M:
Bupropione nel trattamento del disturbo depressivo maggiore: confronto con paroxetinaGiorn. Ital Psicopat., 16, 128-133, 2010
44. Casey DE, Carson WH, Saha AR, Liebeskind A, Ali MW, Jody D, Ingenitoon GG:
Switching patients to aripiprazole from other antipsychotic agents: a multicenter randomized study. Psychopharmacol., 166, 391-399, 2003
45. Chrzanowski WK, Marcus RN, Torbeyns A, Nylas M, McQuade RD:
Effectiveness of long-term aripripazole therapy in patients with acutely relapsing or chronic, stable schizophrenia: a 52-week, open-label comparison with olanzapine. Psychopharmacol., 189, 259-266, 2006
46. Clayton AH, Croft HA, Horrigan JP, Wightman DS, Krishen A, Richard NE, Modell JG:
Bupropion extended release compared with escitalopram : effects on sexual functioning and antidepressant efficacy in 2 randomized, double-blind, placebo-controlled studies. J Clin Psychiatry , 67, (5), 736-746, 2006
Burden of phase-specific sexual dysfunction with SSRIs. J Affect Disord, 91, 27-32, 2006
48. Clayton A, Kornstein S, Prakash A, Mallinckrodt C, Wolreich M:
Changes in sexual functioning associated with duloxetine, escitalopram, and placebo in the treatment of patients with major depressive disorder. J Sex Med, 4, (1), 917-29, 2007
49. Clayton AH, McGarvey EL, Abouesh AI, Pinkerton RC
Substitution of an SSRI with bupropion sustained release following SSRI-induced sexual dysfunction. J Clin Psychiatry , 62, (3), 185-90, 2001
The Changes in Sexual Functioning Questionnaire (CSFQ): development, reliability, and validity. Psychopharmacol. Bull. 33, 731–745, 1997
51. Clayton AH, Pradko JF, Croft HA, Montano CB, Leadbetter RA, Bolden-Watson C, Bass
Prevalence of sexual dysfunction among newer antidepressants.
52. Clayton AH, Zajecka J, Ferguson JM, Filipiak-Reisner JK, Brown MT, Schwartz
Lack of sexual dysfunction with the selective noradrenaline reuptake inhibitor reboxetine during treatment for major depressive disorder. Int Clin Psychopharmacol., 18, (3), 151-6, 2003
53. Clayton AH, Warnock JK, Kornstein SG, Pinkerton R, Sheldon-Keller A, McGarvey EL :
A placebo-controlled trial of bupropion SR as an antidote for selective serotonin reuptake inhibitor-induced sexual dysfunction. J Clin Psychiatry , 65, (1), 62-7, 2004
Depressione e sessualitàHippocrates Edizioni Medico-Scientifiche, Milano, 2001
55. Cohen S, Kühn K-U, Bender S, Erfurth A, Gastpar M., Murafi A, Rothermundt M,
Signerski J, Sträter B, Teusch L, Weig W, Welling A, Westheide J, Huber TJ:
Sexual impairment in psychiatric inpatients: focus on depression. Pharmacopsychiatry, 40, 2, 58-63, 2007
56. Coleman C, King B, Bolden-Watson C, Bolden- Watson C, Book M J, Segraves RT,
Richard N, Ascher J, Batey S, Jamerson B, Metz A:
A placebo-controlled comparison of the effects on sexual functioning of bupropion sustained release and fluoxetine. Clin Therapeutics, 23, 7, 1040-1058 , 2001
Priapism associated with conventional and atypical antipsychotic medications: a review. J Clin Psychiatry, 62, (5), 362-366, 2001
Sexual side effects associated with conventional and atypical antipsychotics. Psychopharmacol Bull., 35, 3, 89-108, 2001
Antipsychotic-induced hyperprolactinemia and sexual dysfunction. Psychopharmacol Bull., 36, 1, 143-164 , 2002
Second-generation antipsychotics for schizophrenia: a review of clinical pharmacology and medication-associated side effects. Isr J Psychiatry Relat Sci., 42, 1, 51-60, 2005
A randomized double-blind study of risperidone and olanzapine in the treatment of schizophrenia or schizoaffective disorder. Am J Psych, 158, 765–774, 2001
62. Corona G, Ricca V, Bandini E, Mannucci E, Lotti F, Boddi V, Rastrelli G, Sforza A, Faravelli C, Forti G, Maggi M:
Selective Serotonin Reuptake Inhibitor-Induced Sexual Dysfunction. J Sex Med, 6, 5, 1259-69, 2009
63. Costa AM, de Lima MS, Faria M, Filho SR, de Oliveira IR, de Jesus Mari J:
A naturalistic, 9-month follow-up, comparing olanzapine and conventional antipsychotics on sexual function and hormonal profile for males with schizophrenia. J Psychopharmacol, 21, 165–170, 2007
A systematic review on clinical management of antipsychotic-induced sexual dysfunction in schizophreniaSao Paulo Med J, 124, (5) 291-7, 2006
Pharmacologic modification of psychosexual dysfunction. J Sex Marital Ther., 13, 239-252, 1987
66. Croft H, Settle E, Houser T, Batey SR, Donahue RMJ, Ascher JA:
A placebo-controlled comparison of the antidepressant efficacy and effects on sexual functioning of sustained-release bupropion and sertraline. Clinical Therapeutics, 21, 4, 643-658, 1999
Sexual dysfunction and antipsychotics treatment. Psychoneuroendocrinology, 28, suppl. 1, 69-82, 2003
68. Cutler AJ, Montgomery SA, Feifel D, Lazarus A, Astrom M, Brecher M:
Extended release quetiapine fumarate monotherapy in major depressive disorder: a placebo- and duloxetine-controlled study. J Clin Psych, 70, 526–539, 2009
69. David SR, Taylor CC, Kinon BJ, Breier A :
The effects of olanzapine, risperidone, and haloperidol on plasma prolactin levels in patients with schizophrenia. Clin Ther, 22, 9, 1085-96, 2000
Sexual dysfunction and antidepressant. Depression, 2, 233-240, 1995
Sexual dysfunction in women using major tranquilizersPsychosomatics, 23, 9, 959-961, 1982
72. Delgado PL, Brannan SK, Mallinckrodt CH, Tran PH, McNamara RK, Wang F, Watkin JG,
Sexual Functioning Assessed in 4 Double-Blind Placebo- and Paroxetine-Controlled Trials of Duloxetine for Major Depressive Disorder
The DSFI: A Multidimensional Measure of Sexual Functioning. J Sex Marital Ther, 5, 244-281, 1979
Sexual dysfunction in schizophrenics patients, the role of antipsychotics. Presse Med, 34, (7), 529-32, 2005
Potential side effects of clozapine on the sexual function of schizophrenic man. J Sex Educ Ther., 26, 4, 334-339, 2001
Comparative safety and tolerability of selective serotonin reuptake inhibitors. Human Psychopharmacology , 10, (suppl.3), 185-193, 1995
Preliminary results from a multi-center trial of clomipramine in obsessive-compulsive disorder. Psychopharm Bull, 25, 36-40, 1989
Neurologist-induced sexual dysfunction: Enzyme-inducing antiepileptic drugs Neurology, 65, (7), 980 – 981, 2005.
Spotlight on bupropion in major depressive disorder. CNS Drugs.;22:613-617, 2
Bupropion. A Review of its use in the management of major depressive disorder. Drugs, 68, 5, 653-689, 2008
Neuroleptic-induced hyperprolactinemia. Schizophr Res., 35, S75-S86, 1999
Bupropion improves sexual functioning in depressed minority women: an open-label switch study. J Clin Psychopharmacol. 2006;26:21Y26.
83. Dossenbach M, Dyachkova Y, Pirildar S, Anders M, Khalil A, Araszkiewicz A,
Shakhnovich T, Akram A, Pecenak J, McBride M, Treuer T:
Effects of atypical and typical antypsichotic treatments on sexual function in patients with schizophrenia: 12-month results from the Intercontinental Schizophrenia Outpatients Health Outcomes (IC-SOHO) study. Eur Psychiatry, 21, 4, 251-258, 2006
84. Dossenbach M, Erol A, el Mahfoud Kessaci M, Shaheen MO, Sunbol MM, Boland J,
Effectiveness of antipsychotic treatments for schizophrenia: interim 6-month analysis from a prospective observational study (IC-SOHO) comparing olanzapine, quetiapine, risperidone, and haloperidol. IC-SOHO Study Group. J Clin Psych, 65, 3, 312–321, 2004
85. Dossenbach M, Hodge A, Anders M, Molnàr B, Peciukaitiene D, Krupka-Matuszczyk I,
Tatu M, Bondar V, Pecenak J, Gorjanc T, McBride M:
Prevalence of sexual dysfunction in patients with schizophrenia: international variation and underestimation. Int. J Neuropsychopharmacol., 8, 195-201, 2005
Treatment of psychotropic-induced hyperprolactinaemia. Psychiatric Bull, 19, 755-757, 1995
Systematic review of sexual problems : epidemiology and methodology. J Sex Marital Ther, 28, 399-422, 2002
88. Eberhard J, Lindström E, Holstad M, Levander S:
Prolactin level durin 5 years of risperidone treatment in patients with psychotic disorders,Acta Psychiatr Scand., 115, 268-276, 2007
89. Fan X, Henderson DC, Chiang E, Briggs LBN, Freudenrich O, Evins AE, Cather C, Goff
Sexual functioning, psychopatology and quality of life in patients with schizophrenia. Schizophr Res, 94, 119-127, 2007
Sexual functioning and SSRIs. J Clin Psychiatry, 63, (suppl. 5), 13-16, 2002
91. Feiger A., Kiev A, Shrivastava RK, Wisselink PG, Wilcox CS:
Nefazodone versus sertraline in outpatients with major depression: focus on efficacy, tolerability, and effects on sexual function and satisfaction. J Clin Psychiatry, 57, (Suppl. 2), 53-62, 1996
The effects of antidepressants on sexual functioning in depressed patients: a review. J Clin Psychiatry, 62, (suppl. 3), 22-34, 2001
93. Ferguson JM, Shrivastava RK, Stahl SM, Hartford JT, Borian F, Ieni J, McQuade RD, Jody
Reemergence of sexual dysfunction in patients with major depressive disorder: double-blind comparison of nefazodone and sertraline. J Clin Psychiatry, 62, (1), 24-9, 2001
Fluoxetine for premature ejaculation.
95. Fortier P, Mottard JP, Trudel G, Even S:
Study of sexuality-related characteristics in young adults with schizophrenia treated with novel neuroleptics and in a comparison group of young adults. Schizophr Bull, 29, 3, 559–572, 2003
Clonazepam-related sexual dysfunction in male veterans with PTSD. Anxiety, 1, 233–236, 1994
97. Fujii A, Yasui-Furukori N, Sugawara N, Sato Y, Nakagami T, Saito M, Kaneko S :
Sexual dysfunction in Japanese patients with schizophrenia treated with antipsychotics. Progress in Neuropsychopharm Biol Psychiatry, 34, 2, 288–293, 2010
Bupropion: an antidepressant without sexual pathophysiological action. J Clin Psychopharmacol., 5, (1), 24-9, 1985
Increased libido in women receiving trazodone. Am J Psychiatry, 143, 781-782, 1986
Gelenberg AJ, McGahuey C, Laukes C, Okayli G, Moreno F, Zentner L, Delgado P:Mirtazapine substitution in SSRI-induced sexual dysfunction. J Clin Psychiatry, 61, 5, 356-69, 2000
Ghadirian AM, Annable L, Bélanger MC:Lithium, benzodiazepines, and sexual function in bipolar patients. Am. J. Psychiatry, 149, 801–805, 1992
Ghadirian AM, Chouinard G, Annable L:Sexual dysfunction and plasma prolactin levels in neuroleptic-treated schizophrenic outpatients. J Nerv Ment Dis, 170, 453-467, 1982
Giammusso B, Morgia G, Spampinato A, Motta M: La paroxetina nel trattamento della eiaculazione precoce Arch Ital Urol Androl, 69, 1, 11-13, 1997
Gil-Nagel A, López-Muñoz F, Serratosa JM, Moncada I, García-García P, Alamo C: Effect of lamotrigine on sexual function in patients with epilepsy. Seizure, 15, 142–149, 2006
Giorgi PM : Trattamento dell’eiaculazione precoce primitiva con inibitori selettivi dei re-uptake
della serotonina (SSRIs). Riv Sessuol, 24, 3, 256-259, 2000
Girgis SM, El-Haggar S, El-Hermouzy S: A double-bind trial of clomipramine in premature ejaculation. Andrologia, 14, 4, 364-368, 1982
Gitlin MJ:Psychotropic medications and their effects on sexual function: diagnosis, biology, and treatment approaches. J. Clin Psychiatry, 56, (9), 406-13, 1994
Gitlin MJ:Effects of depression and antidepressants on sexual functioning. Bull Menninger Clin., 59, (2), 232-48, 1995
Gitlin M.:Sexual dysfunction with psychotropic drugs. Expert Opin Pharmacother., 4, (12), 2259-69, 2003
Gitlin MJ, , Suri R, Altshuler L, Zuckerbrow-Miller J, Fairbanks L: Bupropion-Sustained Release as a Treatment for SSRI-Induced Sexual Side Effects. Journal of Sex & Marital Therapy, 28:131–138, 2002
Goodnick PJ, Rodriguez L, Santana O:Antipsychotics: impact on prolactin levels. Exp Opin Pharm, 3, 1381–1391, 2002
Gopalakrishnan R, Jacob KS, Kuruvilla A, Vasantharaj B, Jacob KJ:Sildenafil in the treatment of antipsychotic-induced erectile dysfunction: a randomized, double-blind, placebo-controlled, flexible-dose, two-way crossover trial. Am J Psychiatry, 163, 494-499, 2006
Gregorian RS, Golden KA, Bahce A, Goodman C, Kwong WJ, Khan ZM:Antidepressant-induced sexual dysfunctionAnn Pharmacother, 36, (10), 1557-89, 2002
Grootens KP, Van Veelen NM, Peuskens J, Sabbe BG, Thys E, Buitelaar JK, Verkes
Ziprasidone versus olanzapine in recent-onset schizophrenia and schizoaffective disorder: results of an 8-week double-blind randomized controlled trial. Schizophr Bull., 37, 2, 352-361, 2011 doi: 10.1093/schbul/sbp037First published online: June 19, 2009
Haberfellner EM:Strategies for managing antidepressant-induced sexual dysfunction: systematic review of randomised controlled trialsPharmacopsychiatry, 40, (5), 173-82, 2007
Haddad PM, Sharma SG: Adverse effects of atypical antipsychotics: differential risk and clinical implications. CNS Drugs, 21, 911–936, 2007
Haddad PM, Wieck A:Antipsychotic-induced hyperprolactinaemia. Mechanisms, clinical features and management. Drugs, 64, (20), 2291-2314, 2004
Haensel SM, Rowland DL, Kallan KTHK, Koos Slob A: Clomipramine and sexual function in men with premature ejaculation and controls. J Urol, 156, 4, 1310-1315, 1996
Haensel SM, Klem TM, Hop WC, Slob AK: Fluoxetine and premature ejaculation: a double-blind, crossover, placebo-controlled study. J Clin Psychopharmacol, 18, 1, 72-77, 1998
Hamer S, Haddad PM:Adverse effects of antipsychotics as outcome measures. Br J Psychiatry, 191, suppl. 50, s64-s70, 2007
Harden CL: Sexuality in men and women with epilepsy. CNS Spectr. 11, 13–18, 2006
Harden CL:Sexuality in women with epilepsy. Epilepsy Behav, 7, suppl.2, S2-6, 2005
Harden CL:Sexual dysfunction in women with epilepsy. Seizure, 17, 2, 131-5, 2008
Haro JM, Salvador-Carulla L:The SOHO (Schizophrenia Outpatient Health Outcome) study. Implications for the treatment of schizophreniaCNS Drugs, 20, 4, 293-301, 2006
Herzog AG, Drislane FW, Schomer DL, Pennell PB, Bromfield EB, Dworetzky BA, Farina EL, Frye CA:Differential effects of antiepileptic drugs on sexual function and hormones in men with epilepsyNeurology , 65, 1016-1020, 2005
Higgins A, Barker P, Begley CM:Neuroleptic medication and sexuality: the forgotten aspect of education and care. J Psychiatr Ment Health Nurs., 12, 439-446, 2005
Hindmarch I:The behavioural toxicity of antidepressants: effects on cognition and sexual function. Int Clin Psychopharmacol., 13, (suppl. 6), 65-8, 1998
Sexual dysfunction in depression: disease or drug-related ?Depression and anxiety, 7, 1, 21-23, 1998
Hirschfeld RM: Management of sexual side effects of antidepressant therapy. J Clin Psychiatry , 60, (suppl. 14), 27–30, 1999
Hirschfeld RM, Vornik LA.:Newer antidepressants: review of efficacy and safety of escitalopram and duloxetine. J Clin Psychiatry , 65,(suppl. 4), 46–52, 2004
Hummer M, Huber J:Hyperprolactinaemia and antipsychotic therapy in schizophrenia-Curr Med Res Opin., 20, (2), 189-97, 2004
Hummer M, Kemmler G, Kurz M, Kurzthaler I, Oberbauer H, Fleischhacker WW:Sexual disturbances during clozapine and haloperidol treatment for schizophrenia. Am J Psychiatry, 156, 631-633, 1999
Isojärvi JI, Löfgren E, Juntunen, KS, Pakarinen AJ, Päivänsalo M, Rautakorpi I, Tuomivaara L:Effect of epilepsy and antiepileptic drugs on male reproductive health. Neurology, 62, 247-253, 2004
Istikoglou C, Vlissides D, Michelidakis K, Michelidakis O: Quality of life: sexual dysfunction in young people with schizophrenia treated with ziprasidone. Eur Neuropsychopharm, 19, S511, 2009
Kaplan PM: The use of serotoninergic uptake inhibitors in the treatment of premature ejaculation. J Sex Marital Ther, 20, 321- 324, 1994
Kara H, Aydin S, Agargun MY, Odabas O, Yilmz Y: The efficacy of fluoxetine in the treatment of premature ejaculation: a double-blind placebo controlled study. J Urol, 156, 1631-1632, 1996
Kaufman KR, Stern L, Mohebati A, Olsavsky A, Hwang J:Ziprasidone-induced priapism requiring surgical treatment. Eur Psychiatry, 21, 1 , 48-50, 2006
Kelly DL, Conley RR:A randomized double-blind 12-week study of quietapine, risperidone or fluphenazine on sexual functioning in people with schizophrenia. Psychoneuroendocrinology, 31, 340-346, 2006
Kelly DL, Conley RR:Sexuality and schizophrenia: a review. Schizophr Bull, 30, 4, 767-779, 2004
Kelly DL, Conley RR:Evaluating sexual function in patients with treatment-resistant schizophrenia. Schizophr Res, 63, 195-196, 2003
Keltner NL, McAfee KM, Taylor CL:Mechanisms and tretments of SSRI-Induced Sexual DysfunctionPerspect Psychiatr Care, 38, 3, 111-116, 2002
Kennedy SH: Favorable sexual profile of agomelatine in depressed patientsEur Neuropsychopharmacol, 16, suppl. 4, S 319, 2006
Kennedy SH, Eisfeld BS, Dickens SE, Bacchiochi JR, Bagby RM: Antidepressant-induced sexual dysfunction during treatment with moclobemide, paroxetine, sertraline, and venlafaxine. J Clin Psychiatry, 61, (4), 276-81, 2000
Kennedy SH, Fulton KA, Bagby RM, Greene AL, Cohen NL, Rafi-Tari S: Sexual function during bupropion or paroxetine tretment of major depressive disorder. Can J Psychiatry, 51, (4), 234-242, 2006
Kennedy SH, Guilleminault C:Antidepressant efficacy of agomelatine 25-50 mg versus venlafaxine 75 -150 mg: two randomized, double blind studies. Eur Neuropsychopharmacol, 16, suppl. 4, S 319-320, 2006
Kennedy SH, Rizvi S, Fulton K, Rasmussen J: A Double-blind comparison of sexual functioning, antidepressant efficacy and tolerability between agomelatine and venlafaxine XR. J. Clin. Psychopharmacol., 28, 3, 329–333, 2008
Kennedy SH, Rizvi S: Sexual dysfunction, depression, and the impact of antidepressants. J. Clin. Psychopharmacol. 29, 157–164, 2009
Kerwin R, Millet B, Herman E, Banki CM, Lublin H, Pans M, Hanssens L, L’Italien
A multicentre, randomized, naturalistic, open-label study between aripripazole and standard of care in the management of community-treated schizophrenic patients. Schizophrenia Trial of Aripripazole: (STAR) study. Eur Psychiatry, 22, 433-443, 2007
Kessler RC, Berglund P, Demler O, Jin R, Koretz D, Merikangas KR, Rush AJ,
The epidemiology of major depressive disorder: results from the National Comorbidity Survey Replication (NCS-R). JAMA 289, 3095–3105, 2003
Khawaja MY:Sexual dysfunction in male patients taking antipsychotics.
J Ayub Med Coll Abbottabad, 17, 3, 73-75, 2005
Kilic S, Ergin H, Baydinc YC :Venlafaxine extended release for the treatment of patients with premature ejaculation: a pilot, single-blind, placebo-controlled, fixed-dose crossover study on short-term administration of an antidepressant drug. International J Andrology, 28, 47-52, 2005
Kim SW, Paick JS: Short-term analysis of the effects of as needed use of sertraline at 5 PM for the treatment of premature ejaculation. Urology, 54, 3, 544-547, 1999
Kim SC, Seo KK: Efficacy and safety of fluoxetine, sertraline and clomipramine in patients with premature ejaculation: a double-blind, placebo controlled study. J Urology, 159, 425-427, 1998
Kindler S, Dolberg OT, Cohen H, Hirschmann S, Kotler M: The treatment of comorbid premature ejaculation and panic disorder with fluoxetine. Clinical Neuropharmacology, 20, 5, 466-471, 1997
Kinzl JF:Major depressive disorder, antidepressants and sexual dysfunction.
Neuropsychiatrie: Klinik, Diagnostik, Therapie und Rehabilitation, 23, 2, 134-8, 2009
Kleinberg DL, Davis JM, de Coster R, Van Baelen B, Brecher M :Prolactin levels and adverse events in patients treated with risperidone. J Clin Psychoharmacol, 19, 1, 57-61, 1999
Knegtering H:Antipsychotic treatment and sexual functioning, the role of prolactin. Ph.D. Thesis, 2003. University Medical Center Groningen, University of Groningen, The Netherlands, Department of Psychiatry.
Knegtering H, Blijd C, Boks MPM :Sexual dysfunction and prolactin levels in patients using classical antipsychotics, risperidone or olanzapine. Schizophr. Res, 36, (1-3), 355-356, 1999
Knegtering H, Boks M, Blijd C, Castelein S, van den Bosch RJ, Wiersma D:A randomized open-label comparison of the impact of olanzapine versus risperidone on sexual functioning. J Sex Mar Ther., 32, 315-326, 2006
Knegtering H, Bruggeman, R: What are the effects of antipsychotics on sexual functioning ? Primary Psychiatry, 14, 2, 51–56, 2007
Knegtering H., Castelein S:Antipsychotics and sexual functioning questionnaire (ASFQ). In: Knegtering, H. (Ed.): Antipsychotic Treatment and Sexual Functioning, the Role of Prolactin. University Medical Center Groningen, The Netherlands, Department of Psychiatry, 2003
Knegtering R, Castelein S, Bous H, Van Der Linde J, Bruggeman R, Kliter H, van
A randomized open-label study of the impact of quetiapine versus risperidone on sexual functioning. J Clin Psychopharmacol, 24, 1, 56-61, 2004
Knegtering H, Van den Bosch R, Castelein S, Bruggeman R, Sytema S, Van Os J:Are sexual side effects of prolactin-raising antipsychotics reducible to serum prolactin? Psychoneuroendocrinology, 33, 711–717, 2008
Knegtering H, Van den Moolen AEGM, Castelein S, Kluiter H, van den Bosch RJ :What are the effects of antipsychotics on sexual dysfunction and endocrine functioning ?Psychoneuroendocrinology, 28, suppl.2, 109-123, 2003
Kotin J, Wilbert DE, Verburg D, Soldinger S:Thioridazine and sexual dysfunctionAm J Psichiatry, 133, 1, 82-85, 1976
Kulik FA, Wilbu R.:Case report of paiful ejaculation as a side effect of amoxapine. Am J Psychiatry, 139, 234-235, 1982
Labbate LA:Psychotropics and sexual dysfunction: the evidence and treatments. Adv Psychosom Med, 29, 107-30, 2008
Lambert M, Conus P, Eide P, Mass R, Karow A, Moritz S, Golks D, Naber D:Impact of present and past antipsychotic side effects on attitude toward typical antipsychotic treatment and adherence. Eur Psychiatry, 19, 7, 415-422, 2004
Langworth S, Bodlund O, Agren S:Efficacy and tolerability of reboxetine compared with citalopram. J Clin Psychopharmacol, 26, 121-127, 2006
La Torre A.: Il trattamento psicofarmacologico dell’eiaculazione precoce: analisi della letteratura. Riv Sessuologia, 23, 4, 379-401, 1999
Impotenze sessuali indotte da psicofarmaci. pag. 381-399, in: Rifelli G, Rifelli G: “Impotenza maschile, femminile, di coppia”. Scione Editore, Roma, 2010
La Torre A, D’Antonio P:Impotenze organiche di natura neurologica. Pag. 353-379, in: Rifelli G, Rifelli G: “Impotenza maschile, femminile, di coppia”. Scione Editore, Roma, 2010
Laumann EO, Paik A, Rosen RC: Sexual dysfunction in the United States: prevalence and predictors. JAMA 281, 537–544, 1999
Lee BH, Kim YK, Park SH :Using aripiprazole to resolve antipsychotic-induced symptomatic hyperprolactinemia: a pilot study. Prog Neuropsychopharmacol Biol Psychiatry, 30, 4, 714-717, 2006
Lee HS, Song DH, Kim CH, Choi HK: An open clinical trial of fluoxetine in the treatment of premature ejaculation. J Clin Psychopharmacol, 16, 5, 379-382, 1996
Lieberman JA, Stroup TS, McEvoy JP, Swartz MS, Rosenheck RA, Perkins DO,
Keefe RSE, Davis SM, Davis CE, Lebowitz BD, Severe J, Hsiao JK:
Effectiveness of antipsychotic drugs in patients with chronic schizophrenia. N Engl J Med, 353, 12, 1209–1223, 2005
Lingjaerde O, Ahlfors UG, Bech P, Dencker SJ, Elgen K:The UKU side effect rating scale. A new comprehensive rating scale for psychotropic drugs and a cross-sectional study of side effects in neuroleptic-treated patients. Acta Psychiatr Scand, suppl. 334, 76, 1-100, 1987
Liu-Seifert H, Kinon BJ, Tennant CJ, Sniadecki J, Volavka J:Sexual dysfunction in patients with schizophrenia treated with conventional antipsychotics or risperidoneNeuropsychiatric Disease and Treatment, 5, 47–54, 2009
Ludovico GM, Corvasce A, Pagliarulo G, Cirillo-Marucco E, Marano A, Pagliarulo
Paroxetine in the treatment of premature ejaculation. Br J Urology, 77, 881-882, 1996
Lukoff D, Gioia-Hasick D, Sullivan G, Golden JS, Nuechterlein KH:Sex education and rehabilitation with schizophrenic male outpatients. Schizophr Bull, 12, 669–677, 1986
Lydiard RB, Howell EF, Laraia MT, Ballenger JC:Sexual side effects of alprazolam. Am. J. Psychiatry, 144, 254–255, 1987
MacHale S, Phanjoo AL: SSRIs to treat sexual dysfunction. Br J Psychiatry, 164, 6, 854, 1994
Macdonald S, Halliday J, MacEwan T, Sharkey V, Farrington S, Wall S, McCreadie RG:Nithsdale schizophrenia surveys 24: sexual dysfunction. Case-control study. Br J Psychiatry, 182, 50-56, 2003
Maguire GA: Prolactin elevation with antipsychotic medications: mechanisms of action and clinical consequences. J Clin Psych, 63, (Suppl 4), 56–62, 2002
Mahmoud A, Hayhurst KP, Drake RJ, Lewis SW:Second Generation Antipsychotics Improve Sexual Dysfunction in Schizophrenia: A Randomised Controlled Trial. Schizophrenia Research and TreatmentVolume 2011, Article ID 596898, 6 pagesdoi:10.1155/2011/596898
Malik P:Sexual dysfunction in schizophrenia. Curr Opin Psychiatry, 20, (2), 138-42, 2007
Malik P:Sexual dysfunction in schizophrenia. Focus, 6, 2, 234-238, 2008
Marder SR, Essock SM, Miller AL, Buchanan RW, Casey DE, Davis JM, Kane JM, Lieberman JA, Schooler NR, Covell N, Stroup S, Weissman AM, Wirshing DA, Hall CS, Pogach L, Pi-Sunyer X, Bigger JT, Friedman A, Yevich SJ, Davis B, Shon S:Physical health monitoring of patients with schizophrenia. Am J Psichiatry, 161, 8, 1334-1349, 2004
Marder SR, McQuade RD, Stock E, Kaplita S, Marcus R, Safferman AZ, Saha A, Ali M, Iwamoto T:Aripiprazole in the treatment of schizophrenia: safety and tolerability in short-term, placebo-controlled trials. Schizophr Res, 61, (2-3), 123-136, 2003
Margolese HC, Assalian P.:Sexual side effects of antidepressants: a review. J Sex Marital Ther, 22, (3), 209-17, 1996
Mathew RJ, Weinman ML: Sexual dysfunctions in depression. Arch. Sex. Behav. 11, 323–328, 1982
McGahuey CA, Gelenberg AJ, Laukes CA, Moreno FA, Delgado PL, McKnight KM, Manber R:
The Arizona Sexual Experience Scale (ASEX): reliability and validity. J. Sex Marital Ther. 26, 25–40, 2000
McMahon CG: Treatment of premature ejaculation with sertraline hydrochloride. Int J Impot Research, 10, 181-184, 1998
McMahon CG, Touma K: Treatment of premature ejaculation with paroxetine hydrochloride as needed: 2 single-blind placebo controlled crossover studiesJ Urol, 161, 6, 1826-1830, 1999
Mendels J, Camera A, Sikes C: Sertraline treatment for premature ejaculation. J Clin Psychopharmacol, 15, 3411-346, 1995
Menon A, Williams RH, Watson S:Increased libido associated with quietiapine. J Psychopharmacol, 20, 1, 125-7, 2006
Michael A, Owen A: Venlafaxine-induced increased libido and spontaneous erections. Br J Psychiatry, 170, 193, 1997
Micheal A, Ramana R:Nefazodone-induced spontaneous ejaculation. Br J Psychiatry, 169, (5), 672-673, 1996
Michelson D, Bancroft J, Targum S, Kim Y, Tepner R:Female sexual dysfunction associated with antidepressant administration: a randomized, placebo-controlled study of pharmacologic intervention. Am J Psychiatry, 157, 2, 239-243, 2000
Mir A, Shivakumar K,Williamson RJ, McAllister V, O’Keane V, Aitchison KJ:Change in sexual dysfunction with aripiprazole: a switching or add-on study. J Psychopharmacol, 22, 244–253, 2008
Modell JG, Katholi CR, Modell JD, DePalma RL:Comparative sexual side effects of bupropion, fluoxetine, paroxetine, and sertraline. Clin Pharmacol Ther., 61, (4), 476-87, 1997
Monteiro WO, Norsirvani HF, Marks IM, Lelliot PT:
Anorgasmia from clomipramine in obsessive-compulsive disorder: a controlled trial. Br J Psychiatry, 151, 107-112, 1987
Montejo AI, Llorca G, Izquierdo JA, Ledesma A, Bousono M, Calcedo A, Carrasco JL, Daniel E, de Dios A, de la Gandara J, Derecho J, Franco M, Gomez MJ, Macias JA, Martin T, Perez V, Sanchez JM, Sanchez S, Vicens E: Disfunciòn sexual secundaria a ISRS. Anàlisis comparativo en 308 pacientes (Sexual dysfunction secondary to SSRIs. A comparative analysis in 308 patients). Actas Luso Esp Neurol Psiquiatr Cienc Afines, 24, 6, 311-321, 1996
Montejo AL:Prolactin awareness: an essential consideration for physical health in schizophrenia. Eur Neuropsychopharmacol., 18, suppl 2, S 108-14, 2008
Montejo AL, Campos MC, Fombellida C, Franco M, Garcia Mellado J, Perez-Urnaiz
A, Olivares JM, Ortega MA, Prieto N, Riesgo Y, Barber I:
Prospective, multicenter, open-label, observational study of sexual function in patients beginning aripiprazole treatment. Eur Psychiatry, 23, S133–S134, 2008
Montejo AL, García M, Espada M, Rico-Villademoros F, Llorca G, Izquierdo JA: Psychometric characteristics of the psychotropic-related sexual dysfunction questionnaire. Spanish work group for the study of psychotropic-related sexual dysfunctions. Actas Esp. Psiquiatr., 28, 141–150, 2000
Montejo AL, Llorca G, Izquierdo JA, Rico-Villademoros F:Incidence of sexual dysfunction associated with antidepressant agents: a prospective multicenter study of 1022 outpatients. Spanish Working Group for the Study of Psychotropic-Related Sexual Dysfunction. J Clin Psychiatry, 62, (suppl. 3),10–21, 2001
Montejo AL, Majadas S, Rico-Villademoros F, Llorca G, de la Gandara J, Franco M,
Frequency of sexual dysfunction in patients with a psychotic disorder receiving antipsychotics. J Sex Med, 7, 3404–3413, 2010
Montejo AL, Prieto N, Terleira A, Matias J, Alonso S, Paniagua G, Naval S, Parra
Better sexual acceptability of agomelatine (25 and 50 mg) compared with paroxetine (20 mg) in healthy male volunteers. An 8-week, placebo-controlled study using the PRSEXDQ-SALSEX scale. J. Psychopharmacol., 24, 1, 111-120, 2010
Montejo AL, Rico-Villademoros F: Psychometric properties of the Psychotropic-Related Sexual Dysfunction Questionnaire (PRSexDQ-SALSEX) in patients with schizophrenia and other psychotic disorders. J Sex Marital Ther, 34, 227–239, 2008
Montejo AL, Rico-Villademoros F:Changes in sexual function for outpatients with schizophrenia or other psychotic disorders treated with ziprasidone in clinical practice settings: a 3-month prospective, observational study. Spanish Working Group for the Study of Psychotropic-Related Sexual DysfunctionJ Clin Psychopharmacol, 28, 5, 568-70, 2008
Montejo-Gonzales AI, Llorca G, Izquierdo JA, Ledesma A, Bousono M, Calcedo A,
Carrasco JL, Ciudad J, Daniel E, de Dios A, de la Gandara J, Derecho J, Franco M,
Gomez MJ, Macias JA, Martin T, Perez V, Sanchez JM, Sanchez S, Vicens E:
SSRI-induced sexual dysfunction: fluoxetine, paroxetine, sertraline, and fluvoxamine in a prospective, multicenter, and descriptive clinical study of 344 patients. J Sex Marital Ther, 23, 3, 176-194, 1997
Montejo González AL, Rico-Villademoros F, Tafalla M, Majadas S :A 6-month prospective observational study on the effects of quetiapina on sexual functioning. J Clin Psychopharmacol, 25, 6, 533-538, 2005
Montgomery S.A., Baldwin D.S., Riley A.: Antidepressant medications: a review of the evidence for drug-induced sexual dysfunctionJ Affect Disord, 69, (1-3), 119-140, 2002
Mullen B, Brar JS, Vagnucci AH, Ganguli R:Frequency of sexual dysfunction in patients with schizophrenia on haloperidol, clozapine, or risperidone. Schizophr Res, 48, 155-158, 2001
Murat Basar M, Atan A, Yildiz M, Baykam M, Aydoganli L: Comparison of sertraline to fluoxetine with regard to their efficacy and side effects in the treatment of premature ejaculation. Arch Esp Urol, 52, 9, 1008-1011, 1999
Murthy S, Wylie K:Sexual problems in patients on antipsychotic medication. Sexual Relationship Ther., 22, 1 97-107, 2007
Nagaraj AK, Pai NB, Rao S: A comparative study of sexual dysfunction involving risperidone, quetiapine, and olanzapine. Indian J Psychiatry, 51, 265–271 2009
Nakonezny PA, Byerly MJ, Rush AJ:The relationship between serum prolactin level and sexual functioning among male outpatients with schizophrenia or schizoaffective disorder: a randomized double-blind trial of risperidone vs. quetiapine. J Sex Marital Ther., 33, 203-216, 2007
NIH: NIH Consensus Development Panel on Impotence. J A M A, 270, (1). 83-90, 1993
Nelson JC, Pritchett YL, Martynorv O, Mallinckrodt CH, Detke MJ:The safety and tolerability of duloxetine compared with paroxetine and placebo: a pooled analysis of 4 clinical trialsJ Clin Psychiatry, 8, 212-219, 2006
Nnaji RN, Friedman T:Sexual dysfunction and schizophrenia: psychiatrist’ attitudes and training needs. Psychiatric Bull, 32, 208-210, 2008
Norden MJ: Buspirone treatment of sexual dysfunction associated with selective serotonin reuptake inhibitors. Depression, 12, 109-112, 1994
Noyes R, Garvey MJ, Cook BL, Samuelson L:Problems with tricyclic antidepressant use in patients with panic disorder or agoraphobia: results of a naturalistic follow-up study. J Clin Psychiatry, 50, 163-169, 1989
Nunes LVA, Dieckmann LHJ, Lacaz FS, Bressan R, Matsuo T, Mari JDJ:The accuracy of the Arizona Sexual Experience Scale (ASEX) to identify sexual dysfunction in patients of the schizophrenia spectrum. Revista de Psiquiatria Clínica, 36, 5, 182-9, 2009
Olfson M, Uttaro T, Carson WH, Tafesse E :Male sexual dysfunction and quality of life in schizophrenia. J Clin Psychiatry, 66, 3, 331-338, 2005
Orazzo C, Bortolotti F, Monteleone P:Gli psicofarmaci e la funzionalità sessuale nella pratica clinica.
Organizzazione Mondiale della Sanità (World Health Organization): ICD-10Masson, 1996
Penovich PE: The effects of epilepsy and its treatment on sexual and reproductive function. Epilepsia, 41, (suppl. 2), S53–S61, 2000
Perez V, Canas F, Tafalla M:A 12-month, open-label, comparative study of quetiapine and risperidone in the acute and long-term treatment of schizophrenia. Int Clin Psychopharmacol, 23, 138–149, 2008
Perlis RH, Laje G, Smoller JW, Fava M, Rush AJ, McMahon FJ:Genetic and Clinical Predictors of Sexual Dysfunction in Citalopram-Treated Depressed PatientsNeuropsychopharmacology, 34, 1819–1828, 2009
Peuskens J: Risperidone in the treatment of patients with chronic schizophrenia: a multinational, multicentre, double-blind, parallel-group study versus haloperidol. Risperidone Study Group. Br J Psychiatry, 166, 712–726, 1995
Peuskens J, Sienaert P, De Hert M:Sexual dysfunction: the unspoken side effect of antipsychotics
Eur Psychiatry, 13, (suppl 1), 23s-30s, 1998
Philipp M, Kohnen R, Benkert O:A comparison study og moclobemide and doxepin in major depression with special reference to effects on sexual dysfunction. Int Clin Psychopharmacol., 7, (3-4), 149-53, 1993
Piazza LA, Markowitz JC, Kocsis JH, Leon AC, Portera L, Miller NL, Adler D:Sexual functioning in chronically depressed patients treated with SSRI antidepressants: a pilot study. Am J Psychiatry, 154, 1757-1759, 1997
Pollack MH, Reiter S, Hammerness P: Genitourinary and sexual adverse effects of psychotropic medication. Int. J. Psychiatry Med., 22, 305–327, 1992
Potkin SG, Saha AR, Kujawa MJ, Carson WH, Ali M, Stock E, Stringfellow J, Ingenito G, Marder SR:Aripiprazole, an antipsychotic with a novel mechanism of action, and risperidone vs placebo in patients with schizophrenia and schizoaffective disorder. Arch Gen Psychiatry, 60, 7, 681-690, 2003
Pryor JL, Althof SE, Steidle C, Rosen RC, Hellstrom WJ, Shabisigh R, Miloslavsky M, Kell S:Efficacy and tolerability of dapoxetine in treatment of premature ejaculation: an integrated analysis of two double-blind, randomised controlled trials. Lancet, 368 (9539), 929-937, 2006
Reeves RR, Kimble R:Prolonged erections associated with ziprasidone treatment: a case report. J Clin Psychiatry, 64, 1, 97-8, 2003
Rettenbacher MA, Hofer A, Ebenbichler C, Baumgartner S, Edlinger M, Engl J, Kaser S, Kemmler G, Malik P, Tschoner A, Fleischhacker WW:Prolactin Levels and Sexual Adverse Effects in Patients With Schizophrenia During Antipsychotic Treatment. J Clin Psychopharmacology, 30, 6, 711-715, 2010doi: 10.1097/JCP.0b013e3181faf0e3
Rosen RC, Lane RM, Menza M:Effects of SSRIs on sexual function: a critical review. J Clin Psychopharmacol., 19, (1), 67-85, 1999
Rosenberg KP, Bleiberg KL, Koscis J, Gross C:A survey of sexual side effects among severely mentally ill patients taking psychotropic medications: impact on compliance. J Sex Marital Ther., 29, (4), 289-296, 2003
Assessment of clinical and metabolic status, and subjective well-being, in schizophrenic patients switched from typical and atypical antipsychotics to ziprasidone.Int Clin Psychopharmacol, 23, 4, 216-22, 2008
Rosso C., Furlan P. M.:La terapia psicosessuologica e psicofarmacologica dell'eiaculazione precoce. Riv Sessuol, 22, 3, 267-279, 1998
Rothschild AJ: Sexual side effects of antidepressants.
J Clin Psychiatry, 61, (suppl 11), 28-36, 2000
Rowland DL, Tai WL, Brummett K, Slob AK:Predicting responsiveness to the tretment of rapid ejaculation with 25 mg clomipramine as needed. Int J Impot Res, 16, 354-357, 2004
Rudkin L, Taylor M, Hawton K:Strategies for managing sexual dysfunction induced by antidepressant medication. Cochrane Database of Systematic Reviews, Issue 4, Art. No.: CD003382, 2004. DOI: 10.1002/14651858.CD003382.pub2.
Safarinejad MR:Comparison of dapoxetine versus paroxetine in patients with premature ejaculation: a double blind, placebo-controlled, fixed-dose, randomized study. Clin Neuropharmacol, 29, (5), 243-52, 2006
Saferinejad MR:Safety and efficacy of escitalopram in the treatment of premature ejaculation: a double-blind placebo-controlled, fixed dose, randomized study. J Clin Psychopharmacol., 27, 5, 444-450, 2006
Safarinejad MR:The effects of the adjunctive bupropion on male sexual dysfunction induced by a selective serotonin reuptake inhibitor: a double-blind placebo-controlled and randomized studyB J U International, 11 febb. 2010doi:10.1111/j.1464-410X.2009.09154.x
Safarinejad MR: Reversal of SSRI-induced female sexual dysfunction by adjunctive bupropion in menstruating women: a double-blind, placebo-controlled and randomized study J Psychopharmacol, 25, 3, 370-378, 2011
Saferinejad MR, Hosseini SY:Safety and efficacy of citalopram in the treatment of premature ejaculation: a double-blind placebo-controlled, fixed dose, randomized study. Int J Impot Res, 18, (2), 164-169, 2006
Safarinejad MR, Hosseini SY, Asgari MA, Dadkhah F, Taghva A:
A randomized, double-blind, placebo-controlled study of the efficacy and safety of bupropion for treating hypoactive sexual desire disorder in ovulating womenB J U International, 11 febb. 2010doi:10.1111/j.1464-410X.2010.09208.x
Saiz-Ruiz J, Montes JM, Ibanez A, Diaz M, Vicente F, Pelegrin C, Vinas R, Arias F, Carrasco JL, Ferrando L:Assessment of sexual functioning in depressed patients treted with mirtazepine: a naturalistic 6-month study. Hum Psychopharmacol., 20, 6, 435-440, 2005
Schweitzer I, Maguire K, Ng C: Sexual side-effects of contemporary antidepressants: reviewAustralian and New Zealand Journal of Psychiatry 2009; 43:795-808
Segraves RT: Effects of psychotropics drugs on human erection and ejaculation. Arch Gen Psychiatry, 46, 275-284, 1989
Segraves RT. Antidepressant-induced sexual dysfunction. J Clin Psychiatry , 59, (suppl. 4), 48–54, 1998
Segraves RT, Croft H, Kavoussi R, Ascher JA, Batey SR, Foster VJ, Bolden-Watson C, Metz A:Bupropion sustained release (SR) for the treatment of hypoactive sexual desire disorder (HSDD) in non depressed women. J of Sex and Marithal Therapy, 27, 303-316, 2001
Segraves RT, Saran A, Segraves K, Maguire E: Clomipramine versus placebo in the treatment of premature ejaculation: a pilot study. J Sex Marital Ther, 19, 3, 198-200, 1993
Serretti A, Chiesa A :Treatment-emergent sexual dysfunction related to antidepressants: a meta-analysis. J Clin Psychoparmacol, 29, 3, 259-66, 2009
Serretti A, Chiesa A :Antidepressivi e disfunzione sessuale: epidemiologia, meccanismi e strategie di trattamento. Giorn Ital Psicopatol, 16, 104- 113, 2010
Serretti A, Chiesa A :A meta-analysis of sexual dysfunction in psychiatric patients taking antipsychotics. International Clinical Psychopharmacology, POST AUTHOR CORRECTIONS, 28 December 2010DOI: 10.1097/YIC.0b013e328341e434
Serretti A, Chiesa A :Sexual Side Effects of Pharmacological Treatment of Psychiatric Diseases. Nature, 89, 1, 142- 147, 2011
Shabsigh R, Patrick DL, Rowland DL, Bull SA, Tesfaye F, Rothman M:Perceived control over ejaculation is central to treatment benefit in men with premature ejaculation: results from phase III trials with dapoxetine. B J U Int, 102, (7), 824-8, 2008
Smith DM, Levitte SS:Association of fluoxetine and return of sexual potency in three elderly man. J Clin Psychiatry, 54, 317-319, 1999
Smith S, Wheeler MJ, Murray R, O’Keane V:The effects of antipsychotic-induced hyperprolactinaemia on the hypotalamic-pituitary-gonadal axis. J Clin Psychopharmacol, 22, 109-114, 2002
Smith SM:The impact of hyperprolactinaemia on sexual function in patients with psychosis. J Psychopharmacol, 22, (2 suppl.), 63-9, 2008
Smith SM, O’Keane V, Murray R:Sexual dysfunction in patients taking conventional antipsychotic medication. Br J Psychiatry, 181, 49-55, 2002
Stahl SM: Stahl’s Essential Psychopharmachology: Neuroscientific Basis and Practical Applications (third edition). Cambridge University Press, 2008
Sthal SM:The psychopharmacology of sex, Part 1: Neurotransmitters and the 3 phases of the human sexual response. J Clin Psychiatry, 62, 2, 80-81, 2001
Sthal SM:The psychopharmacology of sex, Part 2: Effects of drugs on the 3 phases of the human sexual response. J Clin Psychiatry, 62, 3, 147-148, 2001
St. Lawrence JS, Madakasira S: Evaluation and treatment of premature ejaculation: a critical review. Comprehensive Psychiatry, 22, 1, 77- 97, 1992
Stimmel GL, Gutierrez MA:Sexual dysfunction and psychotropic medicationsCNS Spectr., 11, (8 Suppl 9), 24-30, 2006
Strassberg DS, De Gouveia Brazao CA, Rowland DL, Tan P, Slob K :Clomipramine in the tratment of rapid (premature) ejaculation. J Sex Marital Ther, 25, 89-101, 1999
Strous RD, Kupchik M, Roitman S, Schwartz S, Gonen N, Mester R, Weizman A,
Comparison between risperidone, olanzapine, and clozapine in the management of chronic schizophrenia: a naturalistic prospective 12-week observational study. Hum Psychopharmacol, 21, 4, 235-243, 2006
Sullivan G :Increased libido in three man treated with trazodone. J Clin Psychiatry, 49, 202-203, 1988
Talbot JA, Sheldrick R, Caswell H, Duncan S: Sexual function in men with epilepsy: how important is testosterone? Neurology. 70, 1346-1352, 2008
Taylor MJStrategies for managing antidepressant-induced sexual dysfunction: a reviewCurr Psychiatry Rep., 8, (6), 431-6, 2006
Taylor MJ, Rudkin L, Hawton KStrategies for managing antidepressant-induced sexual dysfunction: systematic review of randomised controlled trials. J Affect Disord, 88 , (3), 241-54, 2005
Thase ME, Clayton AH, Haight BR, Thompson AH, Modell JG, Johnston Ja: A double-blind comparison between bupropion XL and venlafaxine XR. Sexual functioning, antidepressant efficacy and tolerabilityJ Clin Psychoparmacol., 26, (5), 482-488, 2006
Thase ME, Haight BR, Richard N, Rockett CB, Mitton M, Modell JG, VanMeter S,
Remission rates following antidepressant therapy with bupropion or selective serotonin reuptake inhibitors: a meta-analysis of original data from 7 randomized controlled trials. J Clin Psychiatry, 66: 974-981, 2005
Treuer T, Anders M, Bitter I, Dobre G, Pecenak J, Dyachkova Y, Harrison G,
Effectiveness and tolerability of schizophrenia tretment in central and eastern Europe: results after 1 year from a prospective, observational study (IC- SOHO). Int J Psychiatr Clin Pract, 10, 2, 78-90, 2006
Uçok A, Incensu C, Aker T, Ercoç S:Sexual dysfunction in patients with schizophrenia on antipsychotic medication. Eur Psychiatry, 22, 328-333, 2007
Van Bruggen M, Van Amelsvoort T,Wouters L, Dingemans P, de Haan L, Linszen
Sexual dysfunction and hormonal changes in first episode psychosis patients on olanzapine or risperidone. Psychoneuroendocrinology, 34, 989–995, 2009
Antidepressant Side Effects in Depression Patients Treated in a Naturalistic Setting: a study of bupropion, moclobemide, paroxetine, sertraline, and venlafaxine. Can J Psychiatry, 47, (2), 174-80, 2002
Versiani M, Moreno R, Ramakers-van Moorsel CJA, Schutte AJ:Comparison of the effects of mirtazepine and fluoxetine in severely depressed patients. CNS Drugs, 19, 137-146, 2005
Villeneuve J, Demers M, Almeras N, Proulx I, Labelle A, Bourget D, Mottard J, Roy
Advantages of quetiapine on sexual dysfunctions: a switch study. Schizophr Bull, 31, 572, 2005
Volavka J, Czobor P, Cooper TB, Sheitman B, Lindenmayer JP, Citrome L, McEvoy
Prolactin levels in schizophrenia and schizoaffective disorder patients treated with clozapine, olanzapine, risperidone, or haloperidol. J Clin Psychiatry, 65, 1, 57-61, 2004
Wade A, Crawford GM, Angus M, Wilson R, Hamilton L: A randomised, double-blind, 24-weekstudy comparing the efficacy and tolerability of mirtazepine and paroxetine in depressed patients in primary care. Int Clin Psychopharmacol., 18, 133-141, 2003
Waldinger MD:Lifelong premature ejaculation: from authorithy-based to evidence-based medicine. B J U Int, 93, 201-207, 2004
Waldinger MD, Olivier B :Selective serotonin reuptake inhibitor-induced sexual dysfunction: clinical and research considerations. Int Clin Psychoparmacol., 13, (Suppl 6), S27-33, 1998
Waldinger MD, Hengeveld MW, Zwinderman AH: Paroxetine treatment of premature ejaculation: a double-bind, randomized, placebo-controlled study. Am J Psychiatry, 151, 1377-1379, 1994
Waldinger MD, Hengenveld MW, Zwinderman AH: Ejaculation-retarding properties of paroxetine in patients with primary premature ejaculation: a double-bind, randomized, dose-response study. Br J Urol, 79, 592-595, 1997
Waldinger MD, Hengeveld MW, Zwinderman AH, Oliver B: Effect of SSRI antidepressant on ejaculation: a double-blind, randomized, placebo-controlled study with fluoxetine, fluvoxamine, paroxetine and sertraline. J Clin Psychopharmacol, 18, 4, 274-281, 1998
Antidepressants and ejaculation: a double-blind, randomized, placebo-controlled, fixed-dose study with paroxetine, sertraline and nafazodone. J Clin Psychopharmacol, 21, (3), 293-297, 2001
Waldinger MD, Zwindermann AH, Olivier B:Antidepressants and ejaculation: a double-blind, randomized, fixed-dose study with mirtazapine and paroxetine. J Clin Psychopharmacol, 23, 467-70, 2003
Waldinger MD, Zwindermann AH, Olivier B:On-demand treatment of premature ejaculation with clomipramine and paroxetine: a randomized, double-blind fixed-dose study with stopwatch assessment. Eur. Urol, 46, (4), 510-6, 2004
Waldinger MD, Zwindermann AH, Schweitzer DH, Olivier B:Relevance of methodological design for the interpretation of efficacy of drug treatment of premature ejaculation: a systematic review and meta-analysis. Int J Impot Res, 16, (4), 369-381, 2004
Walker PW, Cole JO, Gardner EA, Hughes AR, Johnston JA, Batey SR, Lineberry CG:Improvement in fluoxetine-associated sexual dysfunction in patients switched to bupropion. J Clin Psychiatry, 54, (12), 459-65, 1993
Warner MD, Peadbody CA, Whiteford HA, Hollister LE:Trazodone and priapism. J Clin Psychiatry, 48, 244-245, 1987
Weisler R, Joyce M, McGill L, Lazarus A, Szamosi J, Eriksson H:Extended release quetiapine fumarate monotherapy for major depressive disorder: results of a double-blind, randomized, placebo-controlled study. CNS Spectr, 14, 299–313, 2009
Werneke U, Northey S, Bhugra D:Antidepressant and sexual dysfunctionActa Psychiatr Scandinav, 114, 6, 384-397, 2006
Westheide J, Cohen S, Bender S, Cooper-Mahkorn D, Erfurth A, Gastpar M, Huber TJ, Maier W, Murafi A, Rothermund M, Signerski J, Sträter B, Teusch L, Weig W, Welling A, Kühn K-U:Sexual dysfunction in psychiatric inpatients the role of antipsychotic medication. Pharmacopsychiatry, 40, 4, 140–145, 2007
Westheide J, Cvetanovska G, Albrecht C, Bliesener N, Cooper-Mahkorn D, Creutz C, Hornung W-P, Klingmüller D, Lemke MR, Maier W, Schubert M, Str ter B, Kühn K-U: Prolactin, subjective well-being and sexual dysfunction: an open label observational study comparing quetiapine with risperidone. J Sex Med., 5, 12, 2816-26, 2008
Triple-blind, placebo-controlled trial of Ginkgo biloba in sexual dysfunction due to
Wieck A, Haddad M:Antipsychotic-induced hyperprolactinaemia in women: pathophysiology, severity and consequences. Selective literature review. Br J Psychiatry, 182, 199-204, 2003
Williams VSL, Baldwin DS, Hogue SL, Fehnel SE, Hollis KA, Edin HM:Estimating the prevalence and impact of antidepressant-induced sexual dysfunction in 2 european countries: a cross-sectional patient survey. J Clin Psychiatry, 67, 204-210, 2006
Wirshing DA, Pierre JM, Marder SR, Saunders CS, Wirshing WC:Sexual side effects of novel antipsychotic medications. Schizophr Res, 56, 25-30, 2002
Wise TN: Sertraline as a treatment for premature ejaculation. J Clin Psychiatry, 55, 417, 1994
Yeragani VK, Gershon S:Priapism related to phenalzine therapy. N Eng J Med., 317, (2), 117-118, 1987
Yilmaz U, Tatlisen A, Turan H, Arman F, Ekmekcioglu O: The effects of fluoxetine on several neurophysiological variables in patients wirth premature ejaculationJ Urol, 161, 1, 107-111, 1999
Yusufi B, Mukherjee S, Flanagan R, Paton C, Dunn G, Page E, Barnes TRE:Prevalence and nature of side effects during clozapine maintenance treatment and the relationship with clozapine dose and plasma concentration. Int Clin Psychopharmacol, 22, 238–243, 2007
Zahariou A, Papaioannou P, Karagiannis G:The efficacy of duloxetine in the treatment of premature ejaculationInternational Urology and Nephrology, 39, 115-118, 2007
Zajecka J:Strategies for the treatment of antidepressant-related sexual dysfunction. J Clin Psychiatry, 62, suppl. 3, 35-43, 2001
Zajecka J, Mitchell S, Fawcett J :Treatment-emergent changes in sexual function with selective serotonin reuptake inhibitors as measured with the Rush Sexual Inventory. Psychopharmacol Bull., 33, 755-760, 1997
The impact of mental illness on sexual dysfunction. Balon R (ed): Sexual Dysfunction. The Brain-Body Connection. Adv Psychosom Med., 29, 89-106, 2008
Zourková A, Cesková E, Hadasová E, Ravcuková B:Links among paroxetine-induced sexual dysfunctions, gender, and CYP2D6 activity. J Sex Marital Ther, 33, 4, 343-55, 2007
Zourková A, Hadasová E:Relationship between CYP 2D6 metabolic status and sexual dysfunction in paroxetine treatment. J Sex Marital Ther., 28, 5, 451-61, 2002
In Kooperation mit: Dr. Matthias Bohnsack Invasive Kardiologie am Klinikum Elmshorn Praxis: Friedenstr. 4, 25335 Elmshorn, Tel: 04121-485757 Patienteninformation Herzkatheteruntersuchung Sehr geehrte Patientin, sehr geehrter Patient, dieses Merkblatt soll Ihnen in Ergänzung zu dem Ihnen ebenfalls vorliegenden Aufklärungsbogen die Herzkatheteruntersuchung näherbringen,
Cannabis et Trouble Déficit de l’Attention (TDA) David Bearman, M.D., Californie (USA) http://davidbearmanmd.com/ Traduction autorisée par l’auteur http://mcforadhd.free.fr/ Les symptômes principaux des types les plus connus du TDAH (Trouble Déficit de l’Attention / Hyperactivité) sont (1) suractivité motrice, (2) inattention et (3) impulsivité (American Psychiatric Associat